Tridacaine Iii Patch
Product Images NDC 73352-835

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tridacaine Iii (NDC 73352-835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trifluent Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tridacaine 01)

FDA Label Image

Figure 1 (Tridacaine 02)

FDA Label Image

Principal Display Panel (15 Patch Pouch Label)

Principal Display Panel (15 Patch Pouch Label)
This is a description of the Trifluent Pharma Tridacaine Lidocaine Patch 5%. Each adhesive patch contains Lidocaine USP. It contains inactive components such as polyethylene terephthalate backing, glycerin, propylene glycol, and more. The usual dosage and prescribing information is available with the product. It is distributed in San Antonio, TX, and should be stored at 20° to 25°C. A warning is included to keep patches out of reach of children, pets, and others. This product comes with 15 patches in envelopes containing 1 patch each.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.